Press Releases Virios Therapeutics, Inc.

Equities

VIRI

US92829J1043

Market Closed - Nasdaq Other stock markets 02:00:00 10/05/2024 am IST			5-day change	1st Jan Change
0.3726 ^USD	-13.15%		-11.54%	-35.20%

29/02	Virios Therapeutics, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	CI
22/01	Virios Therapeutics Announces Plans to Advance Development of Imc-2 as Treatment for Symptoms Associated with Long-Covid	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Virios Therapeutics Announces First Quarter 2024 Financial Results and Provides Corporate Update	09/05	AQ
Virios Therapeutics to Report First Quarter 2024 Financial Results on Thursday, May 9, 2024	02/05	AQ
Virios Therapeutics Announces Publication of International Patent for IMC-2 Covering Antiviral Treatment of Long-COVID	26/03	AQ
Virios Therapeutics Announces Fourth Quarter and Full Year 2023 Financial Results	01/03	AQ
Virios Therapeutics Issues Shareholder Letter Highlighting Corporate Progress and Key Upcoming Milestones	29/02	AQ
Virios Therapeutics Announces Fourth Quarter and Full Year 2023 Financial Results	29/02	AQ
Virios Therapeutics Issues Shareholder Letter Highlighting Corporate Progress and Key Upcoming Milestones	28/02	AQ
Virios Therapeutics Announces Plans to Advance Development of IMC-2 as Treatment for Symptoms Associated with Long-COVID	22/01	AQ
Virios Therapeutics, Inc. Reaches Alignment with FDA on Requirements for Advancing Development Candidate IMC-2 as Treatment for Long-COVID	02/01	AQ
Virios Therapeutics Announces Third Quarter 2023 Financial Results and Provides Corporate Update	13/11	AQ
Virios Therapeutics to Report Third Quarter 2023 Financial Results on Monday, November 13, 2023	06/11	AQ
Thinking about buying stock in Aware, Virios Therapeutics, Bit Brother, Confluent, or Blue Star Foods?	03/11	PR
Virios Therapeutics to Present at the ThinkEquity Conference on Thursday, October 19, 2023	12/23/12	AQ
Virios Therapeutics Announces Termination of At-The-Market Sales Agreement	18/23/18	AQ
Virios Therapeutics CEO Greg Duncan to Present at the SHARE Series Investor Event on Monday, September 18, 2023	13/23/13	AQ
Virios Therapeutics CEO Greg Duncan to Present at the SHARE™️ Series Investor Event on Monday, September 18, 2023	12/23/12	AQ
Virios Therapeutics Announces Halt to At-The-Market Offering Sales	14/23/14	AQ
Virios Therapeutics Announces Second Quarter 2023 Financial Results and Provides Corporate Update	10/23/10	AQ
Virios Therapeutics Announces Plans to Advance Lead Candidate IMC-1 to Phase 3 Development as a New Treatment Option for Fibromyalgia	09/23/09	AQ
Virios Therapeutics to Report Second Quarter 2023 Financial Results on Thursday, August 10, 2023	04/23/04	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Virios Therapeutics, Inc.

Equities

VIRI

US92829J1043

Press Releases

Filters